S100 to receptor for advanced glycation end-products binding assay: Looking for inhibitors

11Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Secreted by tumor and stromal cells, S100 proteins exert their biological functions via the interaction with surface receptors. The most described receptor is the receptor for advanced glycation end-products (RAGE), thereby participating in the S100-dependent cell migration, invasion, tumor growth, angiogenesis and metastasis. Several approaches have been described for determining this interaction. Here we describe an easy, specific and highly reproducible ELISA-based method, by optimizing several parameters such as the binding and blocking buffer, interaction time and concentrations, directed to screen chemical and biological inhibitors of this interaction for S100A4, S100A7 and S100P proteins. The efficiency of the protocol was validated by using well described neutralizing agents of the RAGE receptor and of the S100A4 activity. The methodology described here will allow future works with other members of the S100 protein family and their receptors. © 2014 Elsevier Inc. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Padilla, L., Dakhel, S., & Hernández, J. L. (2014). S100 to receptor for advanced glycation end-products binding assay: Looking for inhibitors. Biochemical and Biophysical Research Communications, 446(1), 404–409. https://doi.org/10.1016/j.bbrc.2014.02.143

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free